Altered presymptomatic AMPA and cannabinoid receptor trafficking in motor neurons of ALS model mice: Implications for excitotoxicity

European Journal of Neuroscience

Volumn 27, Issue 3, 2008, Pages 572-579

  Zhao, Pingwei ^a   Ignacio, Sheila ^a   Beattie, Eric C ^a   Abood, Mary E ^a  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

AMPA receptor; Amyotrophic lateral sclerosis; Cannabinoid receptor; Excitotoxicity; G93A; Glutamate receptor

Indexed keywords

AMPA RECEPTOR; CALCIUM ION; CANNABINOID RECEPTOR; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR 1; GLUTAMATE RECEPTOR 2; RECEPTOR SUBTYPE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; EXCITOTOXICITY; FEMALE; GENE EXPRESSION; IMMUNOFLUORESCENCE MICROSCOPY; MALE; MOTONEURON; MOUSE; NERVE CELL NECROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SYNAPSE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; CELL DEATH; DISEASE MODELS, ANIMAL; DOWN-REGULATION; FEMALE; GLUTAMIC ACID; HUMANS; MALE; MICE; MICE, TRANSGENIC; MOTOR NEURONS; NERVE DEGENERATION; NEURAL INHIBITION; NEUROTOXINS; PROTEIN TRANSPORT; RECEPTOR, CANNABINOID, CB1; RECEPTORS, AMPA; SPINAL CORD; SYNAPTIC TRANSMISSION; UP-REGULATION;

EID: 39049161976     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2008.06041.x     Document Type: Article

References (50)

1. Abood, M.E., Rizvi, G., Sallapudi, N. McAllister, S.D. (2001) Activation of the CB(1) cannabinoid receptor protects cultured mouse spinal neurons against excitotoxicity. Neurosci. Lett., 309, 197 201.
2. Bar-Peled, O., O'Brien, R.J., Morrison, J.H. Rothstein, J.D. (1999) Cultured motor neurons possess calcium-permeable AMPA/kainate receptors. Neuroreport, 10, 855 859.
3. Beattie, E.C., Stellwagen, D., Morishita, W., Bresnahan, J.C., Ha, B.K., Von Zastrow, M., Beattie, M.S. Malenka, R.C. (2002) Control of synaptic strength by glial TNFalpha. Science, 295, 2282 2285.
4. Benito, C., Nunez, E., Tolon, R.M., Carrier, E.J., Rabano, A., Hillard, C.J. Romero, J. (2003) Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains. JNeurosci., 23, 11136 11141.
5. Bernardino, L., Xapelli, S., Silva, A.P., Jakobsen, B., Poulsen, F.R., Oliveira, C.R., Vezzani, A., Malva, J.O. Zimmer, J. (2005) Modulator effects of interleukin-1beta and tumor necrosis factor-alpha on AMPA-induced excitotoxicity in mouse organotypic hippocampal slice cultures. JNeurosci., 25, 6734 6744.
6. Bilsland, L., Pryce, G., Baker, D. Greensmith, L. (2004) The neuroprotective effects of cannabinoids in the SOD1G93A mouse model of ALS. Amyotrophic Later. Scler. Motor Neuron Disord., 5, 92.
7. Boillee, S., Vande Velde, C. Cleveland, D.W. (2006) ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron, 52, 39 59.
8. Brown, R.H. Jr. (1997) Amyotrophic lateral sclerosis. Insights from genetics. Arch. Neurol., 54, 1246 1250.
9. Carriedo, S., Yin, H. Weiss, J. (1996) Motor neurons are selectively vulnerable to AMPA/kainate receptor-mediated injury in vitro. JNeurosci., 16, 4069 4079.
10. Centonze, D., Rossi, S., Finazzi-Agro, A., Bernardi, G. Maccarrone, M. (2007) The (endo)cannabinoid system in multiple sclerosis and amyotrophic lateral sclerosis. Int. Rev. Neurobiol., 82, 171 186.
11. Chen, L.-C., Smith, A.P., Yong, B., Zukic, B., Ignacio, S., Moore, D.H. M, L.N. (2004) Temporal gene expression patterns in G93A/SOD1 mouse. Amyotroph Lateral. Scler. Motor Neuron Disord., 5, 164 171.
12. Cleveland, D.W. Rothstein, J.D. (2001) From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat. Rev. Neurosci., 2, 806 819.
13. Corona, J.C. Tapia, R. (2007) Ca(2+)-permeable AMPA receptors and intracellular Ca(2+) determine motoneuron vulnerability in rat spinal cord in vivo. Neuropharmacology, 52, 1219 1228.
14. Ferguson, A.R., Christensen, R.N., Gensel, J.C., Miller, B.A., Beattie, E.C., Bresnahan, J.C. Beattie, M.S. (2006) Effect of tumor necrosis factor-alpha on AMPA-type glutamate receptor trafficking in spinal cord neurons in vivo. Proc. (2006) Abstract Viewer and Itinerary Planner. Society for Neuroscience, City, pp. 475.411.
15. Gong, J.P., Onaivi, E.S., Ishiguro, H., Liu, Q.R., Tagliaferro, P.A., Brusco, A. Uhl, G.R. (2006) Cannabinoid CB2 receptors: immunohistochemical localization in rat brain. Brain Res., 1071, 10 23.
16. Gurney, M.E., Cutting, F.B., Zhai, P., Doble, A., Taylor, C.P., Andrus, P.K. Hall, E.D. (1996) Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis. Ann. Neurol., 39, 147 157.
17. Hermann, G.E., Rogers, R.C., Bresnahan, J.C. Beattie, M.S. (2001) Tumor necrosis factor-alpha induces cFOS and strongly potentiates glutamate-mediated cell death in the rat spinal cord. Neurobiol. Dis., 8, 590 599.
18. Ignacio, S., Moore, D.H., Smith, A.P. Lee, N.M. (2005) Effect of neuroprotective drugs on gene expression in G93A/SOD1 mice. Ann. N Y Acad. Sci., 1053, 121 136.
19. Jarai, Z., Wagner, J., Varga, K., Lake, K., Compton, D., Martin, B., Zimmer, A., Bonner, T., Buckley, N., Mezey, E., Razdan, R., Zimmer, A. Kunos, G. (1999) Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. Proc. Natl Acad. Sci. USA, 96, 14136 14141.
20. Kawahara, Y., Kwak, S., Sun, H., Ito, K., Hashida, H., Aizawa, H., Jeong, S.Y. Kanazawa, I. (2003) Human spinal motoneurons express low relative abundance of GluR2 mRNA: an implication for excitotoxicity in ALS. JNeurochem., 85, 680 689.
21. Kim, K., Moore, D.H., Makriyannis, A. Abood, M.E. (2006a) AM1241, a cannabinoid CB2 receptor selective compound, delays disease progression in a mouse model of amyotrophic lateral sclerosis. Eur. J. Pharmacol., 542, 100 105.
22. Kim, S.H., Won, S.J., Mao, X.O., Jin, K. Greenberg, D.A. (2006b) Molecular mechanisms of cannabinoid protection from neuronal excitotoxicity. Mol. Pharmacol., 69, 691 696.
23. Klivenyi, P., Ferrante, R.J., Matthews, R.T., Bogdanov, M.B., Klein, A.M., Andreassen, O.A., Mueller, G., Wermer, M., Kaddurah-Daouk, R. Beal, M.F. (1999) Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nat. Med., 5, 347 350.
24. Kuner, R., Groom, A.J., Bresink, I., Kornau, H.C., Stefovska, V., Muller, G., Hartmann, B., Tschauner, K., Waibel, S., Ludolph, A.C., Ikonomidou, C., Seeburg, P.H. Turski, L. (2005) Late-onset motoneuron disease caused by a functionally modified AMPA receptor subunit. Proc. Natl Acad. Sci. USA, 102, 5826 5831. Epub 2005 April 5812.
25. Leonoudakis, D., Braithwaite, S.P., Beattie, M.S. Beattie, E.C. (2004) TNFalpha-induced AMPA-receptor trafficking in CNS neurons; relevance to excitotoxicity? Neuron Glia Biol., 1, 263 273.
26. Ludolph, A.C., Meyer, T. Riepe, M.W. (2000) The role of excitotoxicity in ALS - what is the evidence? JNeurol., 247, I7 I16.
27. Ogoshi, F., Yin, H.Z., Kuppumbatti, Y., Song, B., Amindari, S. Weiss, J.H. (2005) Tumor necrosis-factor-alpha (TNF-alpha) induces rapid insertion of Ca2+-permeable alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate (AMPA)/kainate (Ca-A/K) channels in a subset of hippocampal pyramidal neurons. Exp. Neurol., 193, 384 393.
28. Pellegrini-Giampietro, D.E., Gorter, J.A., Bennett, M.V. Zukin, R.S. (1997) The GluR2 (GluR-B) hypothesis: Ca(2+)-permeable AMPA receptors in neurological disorders. Trends Neurosci., 20, 464 470.
29. Raman, C., McAllister, S.D., Rizvi, G., Patel, S.G., Moore, D.H. Abood, M.E. (2004) Amyotrophic lateral sclerosis: delayed disease progression in mice by treatment with a cannabinoid. Amyotroph Lateral Scler. Motor Neuron Disord., 5, 33 39.
30. Robberecht, W. (2000) Oxidative stress in amyotrophic lateral sclerosis. JNeurol., 247, I1 I6.
31. Rosen, D., Siddique, T., Patterson, D., Figlewicz, D., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J., Deng, H., Rahmani, Z., Krizus, A., McKenna-Yasek, D., Cayabyab, A., Gaston, S., Berger, R., Tanzi, R., Halperin, J., Herzfeldt, B., Bergh, R.V.D., Hung, W.-Y., Bird, T., Deng, G., Mulder, D., Smyth, C., Laing, N., Soriano, E., Pericak-Vance, M., Haines, J., Rouleau, G., Gusella, J., Horvitz, H.& Jr, R.B. (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature, 362, 59 62.
32. Roy, J., Minotti, S., Dong, L., Figlewicz, D. Durham, H. (1998) Glutamate potentiates the toxicity of mutant Cu/Zn-superoxide dismutase in motor neurons by postsynaptic calcium-dependent mechanisms. JNeurosci., 18, 9673 9684.
33. Shoemaker, J.L., Seely, K.A., Reed, R.L., Crow, J.P. Prather, P. (2007) The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset. JNeurochem., 101, 87 98.
34. Spalloni, A., Geracitano, R., Berretta, N., Sgobio, C., Bernardi, G., Mercuri, N.B., Longone, P. Ammassari-Teule, M. (2006) Molecular and synaptic changes in the hippocampus underlying superior spatial abilities in pre-symptomatic G93A+/+ mice overexpressing the human Cu/Zn superoxide dismutase (Gly93->ALA) mutation. Exp. Neurol., 197, 505 514.
35. Stellwagen, D., Beattie, E.C., Seo, J.Y. Malenka, R.C. (2005) Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha. JNeurosci., 25, 3219 3228.
36. Sun, H., Kawahara, Y., Ito, K., Kanazawa, I. Kwak, S. (2006) Slow and selective death of spinal motor neurons in vivo by intrathecal infusion of kainic acid: implications for AMPA receptor-mediated excitotoxicity in ALS. JNeurochem., 98, 782 791.
37. Tateno, M., Sadakata, H., Tanaka, M., Itohara, S., Shin, R.M., Miura, M., Masuda, M., Aosaki, T., Urushitani, M., Misawa, H. Takahashi, R. (2004) Calcium-permeable AMPA receptors promote misfolding of mutant SOD1 protein and development of amyotrophic lateral sclerosis in a transgenic mouse model. Hum. Mol. Genet., 13, 2183 2196. Epub 2004 August 2184.
38. Tortarolo, M., Grignaschi, G., Calvaresi, N., Zennaro, E., Spaltro, G., Colovic, M., Fracasso, C., Guiso, G., Elger, B., Schneider, H., Seilheimer, B., Caccia, S. Bendotti, C. (2006) Glutamate AMPA receptors change in motor neurons of SOD1G93A transgenic mice and their inhibition by a noncompetitive antagonist ameliorates the progression of amytrophic lateral sclerosis-like disease. JNeurosci. Res., 83, 134 146.
39. Van Sickle, M.D., Duncan, M., Kingsley, P.J., Mouihate, A., Urbani, P., Mackie, K., Stella, N., Makriyannis, A., Piomelli, D., Davison, J.S., Marnett, L.J., Di Marzo, V., Pittman, Q.J., Patel, K.D. Sharkey, K.A. (2005) Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science, 310, 329 332.
40. Vandenberghe, W., Robberecht, W. Brorson, J. (2000) AMPA receptor calcium permeability, GluR2 expression, and selective motoneuron vulnerability. JNeurosci., 20, 123 132.
41. Walter, L., Franklin, A., Witting, A., Wade, C., Xie, Y., Kunos, G., Mackie, K. Stella, N. (2003) Nonpsychotropic cannabinoid receptors regulate microglial cell migration. JNeurosci., 23, 1398 1405.
42. Weydt, P., Hong, S., Witting, A., Moller, T., Stella, N. Kliot, M. (2005) Cannabinol delays symptom onset in SOD1 (G93A) transgenic mice without affecting survival. Amyotroph Lateral Scler. Motor Neuron Disord., 6, 182 184.
43. Weydt, P. Moller, T. (2005) Neuroinflammation in the pathogenesis of amyotrophic lateral sclerosis. Neuroreport, 16, 527 531.
44. Weydt, P., Yuen, E.C., Ransom, B.R. Moller, T. (2004) Increased cytotoxic potential of microglia from ALS-transgenic mice. Glia, 48, 179 182.
45. Witting, A., Weydt, P., Hong, S., Kliot, M., Moller, T. Stella, N. (2004) Endocannabinoids accumulate in spinal cord of SOD1 G93A transgenic mice. JNeurochem., 89, 1555 1557.
46. Wotherspoon, G., Fox, A., McIntyre, P., Colley, S., Bevan, S. Winter, J. (2005) Peripheral nerve injury induces cannabinoid receptor 2 protein expression in rat sensory neurons. Neuroscience, 135, 235 245.
47. Yiangou, Y., Facer, P., Durrenberger, P., Chessell, I.P., Naylor, A., Bountra, C., Banati, R.R. Anand, P. (2006) COX-2, CB2 and P2X7- immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord. BMC Neurol., 6, 12.
48. Zang, D.W., Lopes, E.C. Cheema, S.S. (2005) Loss of synaptophysin- positive boutons on lumbar motor neurons innervating the medial gastrocnemius muscle of the SOD1G93A G1H transgenic mouse model of ALS. JNeurosci. Res., 79, 694 699.
49. Zhu, S., Stavrovskaya, I.G., Drozda, M., Kim, B.Y., Ona, V., Li, M., Sarang, S., Liu, A.S., Hartley, D.M., du Wu, C., Gullans, S., Ferrante, R.J., Przedborski, S., Kristal, B.S. Friedlander, R.M. (2002) Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature, 417, 74 78.
50. Zimmer, A., Zimmer, A., Hohmann, A., Herkenham, M. Bonner, T. (1999) Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proc. Natl Acad. Sci. USA, 5780 5785.